Retatrutide TRIUMPH-1 (2023) and TRIUMPH-2 (2024) TRIUMPH-1 (Jastreboff et al., NEJM 2023): 338 non-diabetic adults with obesity, 48 weeks at escalating doses: 12 mg dose: 24.2% weight loss 8 mg dose: 22.8% 4 mg dose: 17.5% Placebo: 2.1% TRIUMPH-2 (Rosenstock et al., Lancet 2024) confirmed effects in T2D patients with concurrent NAFLD improvement (hepatic fat reduction 54% at 24 weeks, 12 mg dose)
If you added 3mL instead of 2mL, your concentration is 3.33mg/mL instead of 5mg/mL
Why choose a peptide blend instead of separate vials
It can also reduce hyperpigmentation, sun spots, wrinkles, acne, and even melasma by eliminating toxins and free radicals from the body
Jednym z ciekawszych dowiadcze dotyczcych BPC-157 byo badanie, w ktrym szczurom przecito cigno Achillesa